Jennifer K. Simpson's Net Worth
$159 Thousand
Who is Jennifer K. Simpson?
Jennifer K. Simpson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include LadRx Corp, EAGLE PHARMACEUTICALS, INC., Panbela Therapeutics, Inc., and DELCATH SYSTEMS, INC..
SEC CIK
Jennifer K. Simpson's CIK is 0001545253
Past Insider Trading and Trends
2020 was Jennifer K. Simpson's most active year for acquiring shares with 7 total transactions. Jennifer K. Simpson's most active month to acquire stocks was the month of February. 2016 was Jennifer K. Simpson's most active year for disposing of shares, totalling 1 transactions. Jennifer K. Simpson's most active month to dispose stocks was the month of May. 2019 saw Jennifer K. Simpson paying a total of $147,000.00 for 2,810,147 shares, this is the most they've acquired in one year. In 2016 Jennifer K. Simpson cashed out on 24,004 shares for a total of $6,001.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
LadRx Corp (LADX) Snapshot price: $1.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Dec 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EAGLE PHARMACEUTICALS, INC. (EGRX) Snapshot price: $5.255
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Panbela Therapeutics, Inc. (PBLA) Snapshot price: $1.17
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 27
| |||
Form 4
| +129.79% | 4.44K |
—
|
—
| 7.87K |
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 4
| +41.25% | 1K |
$2.74 | $2,737.10 | 3.42K |
Sep 10
| |||
Form 4
|
∞
| 2.42K |
—
|
—
| 2.42K |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DELCATH SYSTEMS, INC. (DCTH) Snapshot price: $4.645
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +227,363.64% | 25.01K |
—
|
—
| 25.02K |
May 6 - May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +7,325.74% | 7.4K |
$1.75 | $12,948.25 | 7.5K |
Sep 28
| |||
Form 4
| +10,000.00% | 100 |
$2.55 | $255.00 | 101 |
Jul 31
| |||
Form 4
| -1.10% | -468.00 |
$0.22 | -$101.70 | 41.91K |
Jun 27
| |||
Form 4
| +280.87% | 31.25K |
—
|
—
| 42.38K |
Feb 8
| |||
Form 4
| -11.87% | -24.00K |
$0.25 | -$6,001.00 | 178.29K |
Jun 16
| |||
Form 4
| +1,121.12% | 201.38K |
—
|
—
| 219.34K |
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
| +38.71% | 3K |
$1.49 | $4,470.00 | 10.75K |
Jun 1
| |||
Form 4
| +3,000.00% | 7.5K |
—
|
—
| 7.75K |
Mar 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||